期刊文献+

辛二酰苯胺异羟肟酸对人卵巢癌细胞恶性表型的抑制作用 被引量:1

The inhibitory effects of suberoylanilide hydroxamic acid on the malignant phenotypes of ovarian carcinoma cells
下载PDF
导出
摘要 目的 探讨辛二酰苯胺异羟肟酸(SAHA)对人卵巢癌细胞恶性表型的作用及其可能的分子作用机制。方法(1)选取2组人卵巢癌细胞(SKOV3和SKOV3/DDP;HO8910和HO8910-PM)后,设置对照组和终浓度为1、3、5及7μmol/L SAHA组(SAHA 1~4组),采用CCK-8法分别检测SAHA对细胞增殖的影响。(2)设置对照组和SAHA 1、2组(2和5μmol/L),Annexin V-FITC/PI双标记流式细胞术分别检测SAHA对细胞凋亡及周期的影响。(3)RT-PCR和Western blot检测SAHA 1~4组表型相关蛋白的表达水平。结果 (1)随着SAHA浓度的增加,SKOV3细胞株SKOV3/DDP及HO8910细胞株48 h光密度(OD)值均呈逐渐降低趋势(均P〈0.05)。(2)48 h SAHA 1、SAHA 2组凋亡率高于对照组(均P〈0.05);SAHA作用48 h,细胞周期发生阻滞,与对照组比较,SAHA 1组和SAHA 2组SKOV3和SKOV3/DDP细胞S期和G2/M期比例增高,HO8910和HO8910-PM细胞G0/G1期比例增高(P〈0.05)。(3)SAHA 1、2组Cyclin B1和Cdc2(p34)的m RNA表达水平均低于对照组,Caspase-3、p21和p53的m RNA表达水平明显高于对照组(P〈0.05);SAHA 1~4组Ac-Histone H3和Ac-Histone H4和p53蛋白的表达较对照组明显增强,Cyclin B1、Cdc2(p34)蛋白的表达减弱。结论 SAHA通过调节恶性表型相关蛋白Caspase-3、p53、Cyclin B1和Cdc2(p34)的表达水平,促进组蛋白乙酰化,抑制卵巢癌细胞增殖,阻滞细胞周期并诱导细胞凋亡。 Objective To explore the effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on ovarian carcinoma. Methods (I) Two groups of ovarian carcinoma cell lines (SKOV3 and SKOV3/DDP, HO8910 and HO8910-PM) were exposed to SAHA (1, 3, 5 and 7 μmol/L SAHA, group 1-group 4). CCK-8 method was employed to evaluate the inhibitory effects of SAHA. (2)Ovarian cancer cell lines treated with SAHA (2 or 5 μmol/L SAHA) were used as 1 and 2 groups. Flow cytometry was performed following staining with Annexin V-FITC and PI for cell cycle and apoptosis. (3) Reverse transcription polymerase chain reaction (RT-PCR) and Western blot assay were used to assess the mRNA and protein expression levels of phenotypic correlation factor. Results ( 1 )After 48 h of SAHA treatment, the OD value of SKOV3, SKOV3/DDP, and HO8910 showed a trend of gradually reduce (P 〈 0.05). (2)The apoptotic rates were significantly higher in SAHA 1 and SAHA 2 groups than those of control group (P 〈 0.05). Compared with control group, after 48 h of SAHA treat- ment, S phase and G2/M phase of SKOV3 and SKOV3/DDP cells increased; G0/G1 phase of HO8910 and HO8910-PM cells increased in SAHA 1 and 2 groups (P 〈 0.05).(3)The expression levels of CyclinB1 and Cdc2 (p34) mRNA were significantly lower in SAHA 1 and 2 groups than those of control group, while the expression levels of Caspase-3, p21 and p53 mRNA expression were significantly higher in SAHA 1 and 2 groups than those of control group. Furthermore, the expression of Ac-Histone H3, Ac-Histone H4, p53 protein were markedly improved, and CyclinB 1, Cdc2(p34) protein decreased in SAHA 1- 4 groups. Conclusion SAHA may suppress cell growth, induce apoptosis and cause cycle arrest in ovarian carcinoma cells by promoting histone aeetylation or modulating their phenotype-related proteins of Caspase-3, p53, CyclinB 1 and Cdc2(p34).
出处 《天津医药》 CAS 2016年第2期149-154,I0003,共7页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(81172371 81472544) 辽宁省科学技术计划项目(2005408001) 辽宁省教育厅优秀人才支持计划(LJQ2014093) 辽宁医学院校长基金项目(XZJJ2014020 XZJJ20140203)
关键词 卵巢肿瘤 细胞凋亡 细胞增殖 恶性表型 辛二酰苯胺异羟肟酸 组蛋白乙酰化 ovarian neoplasms apoptosis cell proliferation malignant phenotype suberoylanilide hydroxamic acid histone acetylation
  • 相关文献

参考文献15

  • 1赵文华,宋静慧.卵巢癌危险因素研究进展[J].国际妇产科学杂志,2013,40(1):50-53. 被引量:18
  • 2Royce SG, Ver'~eris K, Karagiannis TC. Flistone deacetvlase inhibi- tor's: can we consider potent anti-neopiasiic agents for the treat- men! of astim~al,l]. Ann Clin hab Sci, 2012,42(3):338-345.
  • 3谷华伟,刘艳,桑军侠,刘菁.组蛋白去乙酰化酶抑制剂的研究进展[J].中国当代医药,2015,22(16):15-21. 被引量:6
  • 4Jin JS, Tsao TY, Sun PC, el al. SAHA i.hil~its the growth of colon tumors by decreasing hist.ne deacetylase and the expression of cy-clin D1 and survivin[J]. Pathol Oncol Res, 2012, 18(3):713-720. doi: 10.1007/s 12253-012-9499-7.
  • 5Xu XD, Yang L, Zheng LY, et al. Suberoylanilide hydroxamie ac- id, an inhibitor of histone deacetylase, suppresses vaseulogenic mimicry and proliferation of highly aggressive pancreatic cancer Pa- Tu8988 cells[J]. BMC Cancer, 2014, 27(14): 373. doi: 10.1186/ 1471-2407-14-373.
  • 6刘朝晖,童英.SAHA与妇科恶性肿瘤关系的研究进展[J].医学综述,2013,19(18):3315-3318. 被引量:3
  • 7Casimiro MC, Crosariol M, Loro E, et al. Cyclins and cell cycle control in cancer and disease [J]. Genes Cancer, 2012, 3(11-12): 649-657. doi : 10.1177/1947601913479022.
  • 8Chen MY, Wan'en SL, Zhen L. Decitabine and suberoylanilide hy- droxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor sup- pressor genes, apoptosis, G2/M arrest and autophagy[J]. Cancer, 2011,117(19) :4424-4438. doi: 10.1002/cncr.26073.
  • 9He H, Liu X, Wang D, et al. SAHA inhibits the transcription initi- ation of HPV18 E6/E7 ~enes in HeLa cervical cancer cellsH1.Gene,2014,553(2):98-104. doi: 10.1016/j.gene.2014.10.O07.
  • 10Phyllis SF, James WJ. Cell cycle-related eyclin B 1 quantification[J]. PLoS One,2009,4(9):e7064. doi: 10.1371/journal.pone.O007064.

二级参考文献98

  • 1王颖,王生余,侯春梅,徐元基,杜芝燕,于晓妉.组蛋白去乙酰化酶抑制剂SAHA阻断MAPK信号通路并诱导HL-60细胞凋亡[J].中国实验血液学杂志,2007,15(2):267-271. 被引量:3
  • 2Chou JL,Su HY,Che n LY,et al. Promoter hypermethylation of FBXO32, a novel TGF-13/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer [J]. Lab Invest, 2010,90 (3) :414-425.
  • 3Lynch HT, Casey M J, Snyder CL, et al. Hereditary ovarian cancer: molecular genetics,pathology, management,and heterogeneity [.I ]. Mol Oncol, 2009,3 (2) : 97-137.
  • 4Lynch HT,Watson P,Bewtra C ,et al. Hereditary ovarian cancer heterogenicity in age at diagnosis [J ].Cancer, 1991,67 (5) : 1460- 1466.
  • 5Rebbeck TR, Mitra N, Domchek SM,et al. Modification of ovarian cancer risk by BRCA1/2 interacting genes in a muhicenter cohort of BRCA 1/2 mutation carriers [J ]. Cancer Res, 2009,69 (14) :5801 - 5810.
  • 6Emmanuel C, Gava N, Kennedy C, et al. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis [J]. PLoS One,2011,6(3) :e17617.
  • 7Braem MG,Onland-Moret NC ,van den Brandt PA ,et al. Reproduc- tive and hormonal factors in association with ovarian cancer in the Netherlands cohort study [J]. Am J Epidemiol,2010,172 (10): 1181-1189.
  • 8Titus-Ernstoff L, Rees JR,Terry KL,et al. Breast-feeding the last born child and risk of ovarian cancer [J]. Cancer Causes Control, 2010,21 (2) :201-207.
  • 9Danforth KN ,Tworoger SS,Hecht JL,et al. Breastfeeding and risk of ovarian cancer in two prospective cohorts [J]. Cancer Causes Control, 2007,18(5) :517-523.
  • 10Rossing MA,Cushing-Haugen KL,Wicklund KG,et al. Recre- ational physical activity and risk of epithelial ovarian cancer [J]. Cancer Causes Control ,2010,21 (4) :485-491.

共引文献24

同被引文献8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部